GMT Capital’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
RSCM
FCMI
NMC
MIM
MS
IC
GMT Capital's TPST Position: Q2 2021 in Review
GMT Capital sold out of Tempest Therapeutics (TPST) in Q2 2021, closing a stake of 272 shares — an estimated $64K sold.
GMT Capital first reported a position in TPST in Q1 2016 and held it in 18 quarters. The position peaked at $7.98M in Q1 2016. 23 funds tracked by Wall St. Rank hold TPST as of Q2 2021.
- GMT Capital reported no remaining Tempest Therapeutics position as of Q2 2021 after selling out during the quarter.
- GMT Capital sold 272 Tempest Therapeutics shares in Q2 2021, an estimated $64K.
- GMT Capital first reported a position in Tempest Therapeutics in Q1 2016 and held it in 18 quarters.
- GMT Capital's Tempest Therapeutics position peaked at $7.98M in Q1 2016.
- 23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2021.
Based on GMT Capital's 13F filing for Q2 2021, filed 13 Aug 2021.